SCHEMBL18201156

SCHEMBL18201156

CCc1nc2ccccc2n1-c1ccc(-c2nc3ccccc3c3c2ccc2ccccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ PDE10A Q9Y233 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ MAPK1 P28482 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ CACNA2D1 P54289 2/20 0.39
▸ GSR P00390 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ AKR1B10 O60218 1/20 0.38
▸ ESR1 P03372 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18201144 0.99 MEN1 (0.43) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL18201168 0.92 PDE10A (0.41) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL18201141 0.90 PDE10A (0.41) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL21935010 0.88 MEN1 (0.41) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL18201153 0.88 PDE10A (0.42) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL18201169 0.86 PDE10A (0.41) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL18845875 0.86 ALDH1A1 (0.41) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL21934005 0.86 MEN1 (0.43) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL18845778 0.85 MEN1 (0.40) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL17915154 0.85 MEN1 (0.46) MEN1KMT2AALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 — — US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 — — US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 — — US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 MEN1 1750/4885KMT2A 1104/4885ALDH1A1 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback